Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: PANCREATIC CANCER, . Treffer: 117

2023

Kaser, S; Hofer, SE; Kazemi-Shirazi, L; Festa, A; Winhofer, Y; Sourij, H; Brath, H; Riedl, M; Resl, M; Clodi, M; Stulnig, T; Ress, C; Luger, A [Other specific types of diabetes and exocrine pancreatic insufficiency (update 2023)].
Wien Klin Wochenschr. 2023; 135(Suppl 1):18-31 Doi: 10.1007/s00508-022-02123-x [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

2022

Oehme, F; Hempel, S; Pecqueux, M; Müssle, B; Hau, HM; Teske, C; von, Bechtolsheim, F; Seifert, L; Distler, M; Welsch, T; Weitz, J; Kahlert, C Short-term preoperative drainage is associated with improved postoperative outcomes compared to that of long-term biliary drainage in pancreatic surgery.
Langenbecks Arch Surg. 2022; 407(3): 1055-1063. Doi: 10.1007/s00423-021-02402-7 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Riedl, JM; Schwarzenbacher, E; Moik, F; Horvath, L; Gantschnigg, A; Renneberg, F; Posch, F; Barth, DA; Stotz, M; Pichler, M; Hatzl, S; Fandler-Höfler, S; Gressenberger, P; Gary, T; Jost, PJ; Greil, R; Ay, C; Djanani, A; Gerger, A; Schlick, K Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRINOX or Gemcitabine/nab-Paclitaxel.
Thromb Haemost. 2022; 122(4):633-645 Doi: 10.1055/a-1548-4847
Web of Science PubMed FullText FullText_MUG

 

Seufferlein, T; Mayerle, J; Bock, S; Brunner, T; Ettrich, TJ; Grenacher, L; Gress, TM; Hackert, T; Heinemann, V; Kestler, A; Sinn, M; Tannapfel, A; Wedding, U; Uhl, W S3-Leitlinie zum exokrinen Pankreaskarzinom Langversion 2.0-Dezember 2021-AWMF-Registernummer: 032/010OL
Z GASTROENTEROL. 2022; 60(11): E812-E909. Doi: 10.1055/a-1856-7346
Web of Science PubMed FullText FullText_MUG

 

Shi, W; Li, C; Wartmann, T; Kahlert, C; Du, R; Perrakis, A; Brunner, T; Croner, RS; Kahlert, UD Sensory Ion Channel Candidates Inform on the Clinical Course of Pancreatic Cancer and Present Potential Targets for Repurposing of FDA-Approved Agents.
J Pers Med. 2022; 12(3): Doi: 10.3390/jpm12030478 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Wagner, D; Haybaeck, J; Wienerroither, V; Bajric, T; Tomberger, A; Schemmer, P; Mischinger, HJ; Kornprat, P Platelet to Lymphocyte Ratio Correlates With Carcinoma Progression in Pancreatic Intra Epithelial Neoplasia.
Anticancer Res. 2022; 42(3): 1413-1419. Doi: 10.21873/anticanres.15611
Web of Science PubMed FullText FullText_MUG

 

2021

Birrer, DL; Golcher, H; Casadei, R; Haile, SR; Fritsch, R; Hussung, S; Brunner, TB; Fietkau, R; Meyer, T; Grützmann, R; Merkel, S; Ricci, C; Ingaldi, C; Di, Marco, M; Guido, A; Serra, C; Minni, F; Pestalozzi, B; Petrowsky, H; DeOliveira, M; Bechstein, WO; Bruns, CJ; Oberkofler, CE; Puhan, M; Lesurtel, M; Heinrich, S; Clavien, PA Neoadjuvant Therapy for Resectable Pancreatic Cancer: A New Standard of Care. Pooled Data From 3 Randomized Controlled Trials.
Ann Surg. 2021; 274(5): 713-720. Doi: 10.1097/SLA.0000000000005126
Web of Science PubMed FullText FullText_MUG

 

Brunner, TB; Haustermans, K; Huguet, F; Morganti, AG; Mukherjee, S; Belka, C; Krempien, R; Hawkins, MA; Valentini, V; Roeder, F ESTRO ACROP guidelines for target volume definition in pancreatic cancer.
Radiother Oncol. 2021; 154: 60-69. Doi: 10.1016/j.radonc.2020.07.052
Web of Science PubMed FullText FullText_MUG

 

Goess, R; Mutgan, AC; Çalışan, U; Erdoğan, YC; Ren, L; Jäger, C; Safak, O; Stupakov, P; Istvanffy, R; Friess, H; Ceyhan, GO; Demir, IE Patterns and Relevance of Langerhans Islet Invasion in Pancreatic Cancer.
Cancers (Basel). 2021; 13(2): Doi: 10.3390/cancers13020249 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Hisada, Y; Garratt, KB; Maqsood, A; Grover, SP; Kawano, T; Cooley, BC; Erlich, J; Moik, F; Flick, MJ; Pabinger, I; Mackman, N; Ay, C Plasminogen activator inhibitor 1 and venous thrombosis in pancreatic cancer.
Blood Adv. 2021; 5(2):487-495 Doi: 10.1182/bloodadvances.2020003149 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Liotta, L; Lange, S; Maurer, HC; Olive, KP; Braren, R; Pfarr, N; Burger, S; Muckenhuber, A; Jesinghaus, M; Steiger, K; Weichert, W; Friess, H; Schmid, R; Algül, H; Jost, PJ; Ramser, J; Fischer, C; Quante, AS; Reichert, M; Quante, M PALLD mutation in a European family conveys a stromal predisposition for familial pancreatic cancer.
JCI Insight. 2021; 6(8): Doi: 10.1172/jci.insight.141532 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Mohamed, AA; Thomsen, A; Follo, M; Zamboglou, C; Bronsert, P; Mostafa, H; Amen, A; Mekawy, M; Grosu, AL; Brunner, TB FAK inhibition radiosensitizes pancreatic ductal adenocarcinoma cells in vitro.
Strahlenther Onkol. 2021; 197(1): 27-38. Doi: 10.1007/s00066-020-01666-0 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Moik, F; Prager, G; Thaler, J; Posch, F; Wiedemann, S; Schramm, T; Englisch, C; Mackman, N; Pabinger, I; Ay, C Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic Cancer.
Arterioscler Thromb Vasc Biol. 2021; 41(11): 2837-2847. Doi: 10.1161/ATVBAHA.121.316463
Web of Science PubMed FullText FullText_MUG

 

Neuwersch-Sommeregger, S; Köstenberger, M; Stettner, H; Pipam, W; Breschan, C; Feigl, G; Likar, R; Egger, M CT-Guided Coeliac Plexus Neurolysis in Patients with Intra-Abdominal Malignancy: A Retrospective Evaluation of 52 Palliative In-Patients.
Pain Ther. 2021; 10(2):1593-1603 Doi: 10.1007/s40122-021-00317-1 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Partelli, S; Sclafani, F; Barbu, ST; Beishon, M; Bonomo, P; Braz, G; de, Braud, F; Brunner, T; Cavestro, GM; Crul, M; Trill, MD; Ferollà, P; Herrmann, K; Karamitopoulou, E; Neuzillet, C; Orsi, F; Seppänen, H; Torchio, M; Valenti, D; Zamboni, G; Zins, M; Costa, A; Poortmans, P European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC): Pancreatic Cancer.
Cancer Treat Rev. 2021; 99: 102208 Doi: 10.1016/j.ctrv.2021.102208
Web of Science PubMed FullText FullText_MUG

 

Prager, GW; Oehler, L; Gerger, A; Mlineritsch, B; Andel, J; Petzer, A; Wilthoner, K; Sliwa, T; Pichler, P; Winder, T; Heibl, S; Gruenberger, B; Laengle, F; Hubmann, E; Korger, M; Pecherstorfer, M; Djanani, A; Neumann, HJ; Philipp-Abbrederis, K; Wöll, E; Trondl, R; Arnold-Schrauf, C; Eisterer, W Comparison of nab-paclitaxel plus gemcitabine in elderly versus younger patients with metastatic pancreatic cancer: Analysis of a multicentre, prospective, non-interventional study.
Eur J Cancer. 2021; 143:101-112 Doi: 10.1016/j.ejca.2020.11.003 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Riedl, JM; Posch, F; Horvath, L; Gantschnigg, A; Renneberg, F; Schwarzenbacher, E; Moik, F; Barth, DA; Rossmann, CH; Stotz, M; Schaberl-Moser, R; Pichler, M; Stöger, H; Greil, R; Djanani, A; Schlick, K; Gerger, A Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis.
Eur J Cancer. 2021; 151: 3-13. Doi: 10.1016/j.ejca.2021.03.040 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Zalyte, E; Dedonyte, V; Kurlinkus, B; Sileikis, A; Schemmer, P; Valius, M Establishment and Characterization of a New Pancreatic Ductal Adenocarcinoma Cell Line Capan-26.
ANTICANCER RES. 2021; 41(3): 1401-1406. Doi: 10.21873/anticanres.14897
Web of Science PubMed FullText FullText_MUG

 

2020

Barth, DA; Brenner, C; Riedl, JM; Prinz, F; Klocker, EV; Schlick, K; Kornprat, P; Lackner, K; Stöger, H; Stotz, M; Gerger, A; Pichler, M External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patients.
Cancer Med. 2020; 9(15):5473-5479 Doi: 10.1002/cam4.3233 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Cruz, AF; Rohban, R; Esni, F Macrophages in the pancreas: Villains by circumstances, not necessarily by actions.
Immun Inflamm Dis. 2020; 8(4):807-824 Doi: 10.1002/iid3.345 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Golob-Schwarzl, N; Puchas, P; Gogg-Kamerer, M; Weichert, W; Göppert, B; Haybaeck, J New Pancreatic Cancer Biomarkers eIF1, eIF2D, eIF3C and eIF6 Play a Major Role in Translational Control in Ductal Adenocarcinoma.
Anticancer Res. 2020; 40(6):3109-3118 Doi: 10.21873/anticanres.14292 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Klocker, EV; Barth, DA; Riedl, JM; Prinz, F; Szkandera, J; Schlick, K; Kornprat, P; Lackner, K; Lindenmann, J; Stöger, H; Stotz, M; Gerger, A; Pichler, M Decreased Activity of Circulating Butyrylcholinesterase in Blood Is an Independent Prognostic Marker in Pancreatic Cancer Patients.
Cancers (Basel). 2020; 12(5): Doi: 10.3390/cancers12051154 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Lozanovski, VJ; Polychronidis, G; Gross, W; Gharabaghi, N; Mehrabi, A; Hackert, T; Schemmer, P; Herr, I Broccoli sprout supplementation in patients with advanced pancreatic cancer is difficult despite positive effects-results from the POUDER pilot study.
Invest New Drugs. 2020; 38(3):776-784 Doi: 10.1007/s10637-019-00826-z [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Moulla, Y; Petersen, TO; Maiwald, B; Bailis, N; Kreuser, N; Lordick, F; Seehofer, D; Sucher, R; Hecker, M; Hoffmeister, A; Jansen-Winkeln, B; Gockel, I [Ablative treatment options for locally advanced unresectable and borderline resectable pancreatic carcinoma].
Chirurg. 2020; 91(4):319-328 Doi: 10.1007/s00104-019-01072-y
Web of Science PubMed FullText FullText_MUG

 

Prades, J; Arnold, D; Brunner, T; Cardone, A; Carrato, A; Coll-Ortega, C; De, Luze, S; Garel, P; Goossens, ME; Grilli, R; Harris, M; Louagie, M; Malats, N; Minicozzi, P; Partelli, S; Pastorekova, S; Petrulionis, M; Price, R; Sclafani, F; Smolkova, B; Borras, JM Bratislava Statement: consensus recommendations for improving pancreatic cancer care.
ESMO Open. 2020; 5(6): e001051 Doi: 10.1136/esmoopen-2020-001051 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Riedl, JM; Posch, F; Prager, G; Eisterer, W; Oehler, L; Sliwa, T; Wilthoner, K; Petzer, A; Pichler, P; Hubmann, E; Winder, T; Burgstaller, S; Korger, M; Andel, J; Greil, R; Neumann, HJ; Pecherstorfer, M; Philipp-Abbrederis, K; Djanani, A; Gruenberger, B; Laengle, F; Wöll, E; Gerger, A The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: post hoc analysis of an Austrian multicenter, noninterventional study.
Ther Adv Med Oncol. 2020; 12: 1758835919900872-1758835919900872. Doi: 10.1177/1758835919900872 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Stotz, M; Barth, DA; Riedl, JM; Asamer, E; Klocker, EV; Kornprat, P; Hutterer, GC; Prinz, F; Lackner, K; Stöger, H; Gerger, A; Pichler, M The Lipase/Amylase Ratio (LAR) in Peripheral Blood Might Represent a Novel Prognostic Marker in Patients with Surgically Resectable Pancreatic Cancer.
Cancers (Basel). 2020; 12(7): Doi: 10.3390/cancers12071798 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2019

Dahlem, C; Barghash, A; Puchas, P; Haybaeck, J; Kessler, SM The Insulin-Like Growth Factor 2 mRNA Binding Protein IMP2/IGF2BP2 is Overexpressed and Correlates with Poor Survival in Pancreatic Cancer.
Int J Mol Sci. 2019; 20(13): Doi: 10.3390/ijms20133204 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Gwiasda, J; Qu, Z; Schrem, H; Oldhafer, F; Winny, M; Klempnauer, J; Grannas, G; Kaltenborn, A Prediction of survival after left-sided pancreatic resection for adenocarcinoma: Introduction of a new prognostic score.
Hepatobiliary Pancreat Dis Int. 2019; 18(6): 569-575. Doi: 10.1016/j.hbpd.2019.06.007
Web of Science PubMed FullText FullText_MUG

 

Homeyer, RS; Roberts, KJ; Sutcliffe, RP; Kaltenborn, A; Mirza, D; Qu, Z; Klempnauer, J; Schrem, H Ventilation after pancreaticoduodenectomy increases perioperative mortality: Identification of risk factors and their relevance in Germany that do not apply in England.
Hepatobiliary Pancreat Dis Int. 2019; 18(4):379-388 Doi: 10.1016/j.hbpd.2019.05.001
Web of Science PubMed FullText FullText_MUG

 

Kaser, S; Winhofer-Stöckl, Y; Kazemi-Shirazi, L; Hofer, SE; Brath, H; Sourij, H; Vila, G; Abrahamian, H; Riedl, M; Weitgasser, R; Resl, M; Clodi, M; Luger, A [Other specific types of diabetes and exocrine pancreatic insufficiency (Update 2019)].
Wien Klin Wochenschr. 2019; 131(Suppl 1): 16-26. Doi: 10.1007/s00508-019-1454-0 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Lembeck, AL; Posch, F; Klocker, EV; Szkandera, J; Schlick, K; Stojakovic, T; Kornprat, P; Lackner, C; Gerger, A; Stoeger, H; Stotz, M; Pichler, M Large platelet size is associated with poor outcome in patients with metastatic pancreatic cancer.
Clin Chem Lab Med. 2019; 57(5):740-744 Doi: 10.1515/cclm-2018-0016
Web of Science PubMed FullText FullText_MUG

 

Roberts, KJ; Bannister, CA; Schrem, H Enzyme replacement improves survival among patients with pancreatic cancer: Results of a population based study.
Pancreatology. 2019; 19(1): 114-121. Doi: 10.1016/j.pan.2018.10.010
Web of Science PubMed FullText FullText_MUG

 

Scheithauer, W; Putora, PM; Grünberger, B; Eisterer, W; Wöll, E; Prager, G; Schaberl-Moser, R; Greil, R; Glatzer, M Patterns of care in metastatic pancreatic cancer: patient selection in clinical routine.
Therap Adv Gastroenterol. 2019; 12(5):1756284819877635-1756284819877635 Doi: 10.1177/1756284819877635 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Schlick, K; Magnes, T; Huemer, F; Ratzinger, L; Weiss, L; Pichler, M; Melchardt, T; Greil, R; Egle, A C-Reactive Protein and Neutrophil/Lymphocytes Ratio: Prognostic Indicator for Doubling overall survival Prediction in Pancreatic Cancer Patients.
J Clin Med. 2019; 8(11): Doi: 10.3390/jcm8111791 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Vujic, J; Marsoner, K; Wienerroither, V; Mischinger, HJ; Kornprat, P The Predictive Value of the CRP-to-Albumin Ratio for Patients With Pancreatic Cancer After Curative Resection: A Retrospective Single Center Study.
In Vivo. 2019; 33(6): 2071-2078. Doi: 10.21873/invivo.11706 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2018

Asamer, E; Szkandera, J; Gibiser, P; Lembeck, AL; Stojakovic, T; Kornprat, P; Lackner, C; Winder, T; Schlick, K; Stöger, H; Gerger, A; Pichler, M; Stotz, M Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer : A retrospective analysis.
Wien Klin Wochenschr. 2018; 130(19-20):569-574 Doi: 10.1007/s00508-018-1383-3 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

El-Heliebi, A; Hille, C; Laxman, N; Svedlund, J; Haudum, C; Ercan, E; Kroneis, T; Chen, S; Smolle, M; Rossmann, C; Krzywkowski, T; Ahlford, A; Darai, E; von Amsberg, G; Alsdorf, W; König, F; Löhr, M; de Kruijff, I; Riethdorf, S; Gorges, TM; Pantel, K; Bauernhofer, T; Nilsson, M; Sedlmayr, P In Situ Detection and Quantification of AR-V7, AR-FL, PSA, and KRAS Point Mutations in Circulating Tumor Cells.
Clin Chem. 2018; 64(3):536-546 Doi: 10.1373/clinchem.2017.281295 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Gilg, MM; Gröchenig, HP; Schlemmer, A; Eherer, A; Högenauer, C; Langner, C Secondary tumors of the GI tract: origin, histology, and endoscopic findings.
Gastrointest Endosc. 2018; 88(1):151-158 Doi: 10.1016/j.gie.2018.02.019
Web of Science PubMed FullText FullText_MUG

 

Mutgan, AC; Besikcioglu, HE; Wang, S; Friess, H; Ceyhan, GO; Demir, IE Insulin/IGF-driven cancer cell-stroma crosstalk as a novel therapeutic target in pancreatic cancer.
Mol Cancer. 2018; 17(1):66-66 Doi: 10.1186/s12943-018-0806-0 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2017

Allam, A; Thomsen, AR; Gothwal, M; Saha, D; Maurer, J; Brunner, TB Pancreatic stellate cells in pancreatic cancer: In focus.
Pancreatology. 2017; 17(4):514-522 Doi: 10.1016/j.pan.2017.05.390
Web of Science PubMed FullText FullText_MUG

 

Egger, J; Schmalstieg, D; Chen, X; Zoller, WG; Hann, A Interactive Outlining of Pancreatic Cancer Liver Metastases in Ultrasound Images.
Sci Rep. 2017; 7(1): 892-892. Doi: 10.1038/s41598-017-00940-z [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Gkika, E; Adebahr, S; Kirste, S; Schimek-Jasch, T; Wiehle, R; Claus, R; Wittel, U; Nestle, U; Baltas, D; Grosu, AL; Brunner, TB Stereotactic body radiotherapy (SBRT) in recurrent or oligometastatic pancreatic cancer : A toxicity review of simultaneous integrated protection (SIP) versus conventional SBRT.
Strahlenther Onkol. 2017; 193(6):433-443 Doi: 10.1007/s00066-017-1099-8
Web of Science PubMed FullText FullText_MUG

 

Hann, A; Bettac, L; Haenle, MM; Graeter, T; Berger, AW; Dreyhaupt, J; Schmalstieg, D; Zoller, WG; Egger, J Algorithm guided outlining of 105 pancreatic cancer liver metastases in Ultrasound.
Sci Rep. 2017; 7(1): 12779-12779. Doi: 10.1038/s41598-017-12925-z [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Holman, RR; Bethel, MA; Mentz, RJ; Thompson, VP; Lokhnygina, Y; Buse, JB; Chan, JC; Choi, J; Gustavson, SM; Iqbal, N; Maggioni, AP; Marso, SP; Öhman, P; Pagidipati, NJ; Poulter, N; Ramachandran, A; Zinman, B; Hernandez, AF; EXSCEL Study Group Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
N Engl J Med. 2017; 377(13): 1228-1239. Doi: 10.1056/NEJMoa1612917 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Khatkov, IE; Izrailov, RE; Khisamov, AA; Tyutyunnik, PS; Fingerhut, A Superior mesenteric-portal vein resection during laparoscopic pancreatoduodenectomy.
Surg Endosc. 2017; 31(3):1488-1495 Doi: 10.1007/s00464-016-5115-3
Web of Science PubMed FullText FullText_MUG

 

Langner, C [Hereditary gastric and pancreatic cancer].
Pathologe. 2017; 38(3):164-169 Doi: 10.1007/s00292-017-0297-6 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Wilson, JM; Mukherjee, S; Brunner, TB; Partridge, M; Hawkins, MA Correlation of 18F-Fluorodeoxyglucose Positron Emission Tomography Parameters with Patterns of Disease Progression in Locally Advanced Pancreatic Cancer after Definitive Chemoradiotherapy.
Clin Oncol (R Coll Radiol). 2017; 29(6):370-377 Doi: 10.1016/j.clon.2017.01.038 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2016

Acar, Y; Tezel, O; Salman, N; Cevik, E; Algaba-Montes, M; Oviedo-García, A; Patricio-Bordomás, M; Mahmoud, MZ; Sulieman, A; Ali, A; Mustafa, A; Abdelrahman, I; Bahar, M; Ali, O; Lester, Kirchner, H; Prosen, G; Anzic, A; Leeson, P; Bahreini, M; Rasooli, F; Hosseinnejad, H; Blecher, G; Meek, R; Egerton-Warburton, D; Ćuti, EĆ; Belina, S; Vančina, T; Kovačević, I; Rustemović, N; Chang, I; Lee, JH; Kwak, YH; Kim, do, K; Cheng, CY; Pan, HY; Kung, CT; Ćurčić, E; Pritišanac, E; Planinc, I; Medić, MG; Radonić, R; Fasina, A; Dean, AJ; Panebianco, NL; Henwood, PS; Fochi, O; Favarato, M; Bonanomi, E; Tomić, I; Ha, Y; Toh, H; Harmon, E; Chan, W; Baston, C; Morrison, G; Shofer, F; Hua, A; Kim, S; Tsung, J; Gunaydin, I; Kekec, Z; Ay, MO; Kim, J; Kim, J; Choi, G; Shim, D; Lee, JH; Ambrozic, J; Prokselj, K; Lucovnik, M; Simenc, GB; Mačiulienė, A; Maleckas, A; Kriščiukaitis, A; Mačiulis, V; Macas, A; Mohite, S; Narancsik, Z; Možina, H; Nikolić, S; Hansel, J; Petrovčič, R; Mršić, U; Orlob, S; Lerchbaumer, M; Schönegger, N; Kaufmann, R; Pan, CI; Wu, CH; Pasquale, S; Doniger, SJ; Yellin, S; Chiricolo, G; Potisek, M; Drnovšek, B; Leskovar, B; Robinson, K; Kraft, C; Moser, B; Davis, S; Layman, S; Sayeed, Y; Minardi, J; Pasic, IS; Dzananovic, A; Pasic, A; Zubovic, SV; Hauptman, AG; Brajkovic, AV; Babel, J; Peklic, M; Radonic, V; Bielen, L; Ming, PW; Yezid, NH; Mohammed, FL; Huda, ZA; Ismail, WN; Isa, WY; Fauzi, H; Seeva, P; Mazlan, MZ 12th WINFOCUS world congress on ultrasound in emergency and critical care.
Crit Ultrasound J. 2016; 8(Suppl 1):12 Doi: 10.1186/s13089-016-0046-8 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

Al-Assar, O; Bittner, MI; Lunardi, S; Stratford, MR; McKenna, WG; Brunner, TB The radiosensitizing effects of Nelfinavir on pancreatic cancer with and without pancreatic stellate cells.
Radiother Oncol. 2016; 119(2):300-5 Doi: 10.1016/j.radonc.2016.03.024
Web of Science PubMed FullText FullText_MUG

 

Weitere 50 Treffer anzeigen
© Med Uni Graz Impressum